Journal of Nutrition EB Program 2010 Early Registration

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, D.
Right arrow Articles by Meydani, S. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, D.
Right arrow Articles by Meydani, S. N.
© 2005 The American Society for Nutritional Sciences J. Nutr. 135:1847-1853, August 2005


Biochemical and Molecular Actions of Nutrients

Vitamin E Increases Production of Vasodilator Prostanoids in Human Aortic Endothelial Cells through Opposing Effects on Cyclooxygenase-2 and Phospholipase A21,2

Dayong Wu3, Liping Liu*, Mohsen Meydani* and Simin Nikbin Meydani

Nutritional Immunology Laboratory and * Vascular Biology Laboratory, Jean Mayer U.S. Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, MA 02111

3To whom correspondence should be addressed. E-mail: dayong.wu{at}tufts.edu.

Impairment of endothelium-dependent vasodilation is associated with the initiation and development of atherosclerosis. Vasodilator prostanoids constitute a protective mechanism in maintaining normal vasomotor function. In the current study, we determined the effect of in vitro vitamin E supplementation at physiologically relevant concentrations (10–60 µmol/L) on the production of the vasodilator prostanoids prostaglandin I2 (PGI2; prostacyclin) and prostaglandin E2(PGE2) by human aortic endothelial cells (HAECs) as well as its underlying mechanism. Results showed that vitamin E dose dependently (10–40 µmol/L) increased the production of both prostanoids by HAECs. This was associated with a dose-dependent (10–40 µmol/L) upregulation of cytosolic phospholipase A2 (cPLA2) expression and arachidonic acid release. In contrast, vitamin E dose dependently (10–60 µmol/L) inhibited cyclooxygenase (COX) activity but did not affect the expression of either COX-1 or COX-2, indicating that the effect of vitamin E on COX activity was post-translational. Thus, vitamin E had opposing effects on the 2 key enzymes in prostanoid biosynthesis; at the concentrations used in this study, this resulted in a net increase in the production of vasodilator prostanoids. The vitamin E–induced increase in PGI2 and PGE2 production may contribute to its suggested beneficial effect in preserving endothelial function.


KEY WORDS: • vitamin E • human aorta endothelial cells • prostanoids • cyclooxygenase • phospholipase A2




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. Berdnikovs, H. Abdala-Valencia, C. McCary, M. Somand, R. Cole, A. Garcia, P. Bryce, and J. M. Cook-Mills
Isoforms of Vitamin E Have Opposing Immunoregulatory Functions during Inflammation by Regulating Leukocyte Recruitment
J. Immunol., April 1, 2009; 182(7): 4395 - 4405.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. G Traber
Heart disease and single-vitamin supplementation
Am. J. Clinical Nutrition, January 1, 2007; 85(1): 293S - 299S.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2005 by American Society for Nutrition